You just read:

Aridis Pharmaceuticals, Inc. Presents Positive Phase 2a Safety and Efficacy Data of Salvecin™ (AR-301) in Patients with Severe Pneumonia Caused by Staphylococcus aureus During the 2017 ASM Microbe Congress

News provided by

Aridis Pharmaceuticals, Inc.

05 Jun, 2017, 10:15 ET